Preoperative Concurrent Radiation Therapy and Chemotherapy for Bulky Stage IB2, IIA, and IIB Carcinoma of the Uterine Cervix With Proximal Parametrial Invasion

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 5, 2008, Pages 1508-1515

  Huguet, Florence ^a   Cojocariu, Oana Maria ^a   Levy, Pierre ^a   Lefranc, Jean Pierre ^b   Darai, Emile ^a   Jannet, Denis ^c   Ansquer, Yan ^c   Lhuillier, Pierre Eugène ^d   Benifla, Jean Louis ^e   Seince, Nathalie ^f   Touboul, Emmanuel ^a  

^a HÔPITAL TENON   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d Fontainebleau Hospital   (France)

^e HÔPITAL ROTHSCHILD   (France)

^f HÔPITAL JEAN VERDIER   (France)

Author keywords

Bulky cervical carcinoma; Concomitant chemoradiation; Prognostic factors; Surgery; Toxicity

Indexed keywords

CHEMOTHERAPY; DECISION MAKING; MULTIVARIANT ANALYSIS; PLATINUM COMPOUNDS; PROBABILITY; RADIOTHERAPY; SURGERY; TUMORS;

ACUTE TOXICITIES; BRACHYTHERAPY; BULKY CERVICAL CARCINOMA; CERVICAL CARCINOMATA; CHEMORADIATION; CISPLATIN; CONCOMITANT CHEMORADIATION; CONCURRENT RADIATION THERAPIES; DOSE RATES; EXTERNAL BEAMS; FLUOROURACIL; LOCAL TUMOR CONTROLS; LYMPH NODES; MULTIVARIATE ANALYSES; PATHOLOGIC COMPLETE RESPONSES; PELVIC RADIATIONS; PREDICTIVE FACTORS; PREOPERATIVE CHEMORADIATION; PRETREATMENT; PROGNOSTIC FACTORS; RESIDUAL TUMORS; REST PERIODS; SURGICAL INTERVENTIONS; TOTAL DOSES; UTERINE CERVIXES; VAGINAL BRACHYTHERAPY;

TOXICITY;

CISPLATIN; FLUOROURACIL;

ADULT; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; UTERINE CERVIX CARCINOMA; VAGINAL HYSTERECTOMY;

ADENOCARCINOMA; ADULT; AGED; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ENDOMETRIUM; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREOPERATIVE CARE; RECURRENCE; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 56649123400     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.03.054     Document Type: Article

References (50)

1. Creasman W.T. New gynaecologic cancer staging. Gynecol Oncol 58 (1995) 157-158
2. Gerbaulet A., Kunkler I.H., Kerr G.R., et al. Combined radiotherapy and surgery: Local control and complications in early carcinoma of the uterine cervix-the Villejuif experience, 1975-1984. Radiother Oncol 23 (1992) 66-73
3. Lanciano R.M., Won M., Coia L.R., et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 20 (1991) 667-676
4. Perez C.A., Grigsby P.W., Camel M.H., et al. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: Update of a non randomized comparison. Int J Radiat Oncol Biol Phys 31 (1995) 703-716
5. Stehman F.B., Bundy B.N., Disaia P.J., et al. Carcinoma of the cervix treated with radiation therapy I. A multivariate analysis of prognostic variables in Gynecologic Oncology Group. Cancer 67 (1991) 2776-2785
6. Eifel P.J., Morris M., Wharton J.T., et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 29 (1994) 9-16
7. Werner-Wasik M., Schmid C.H., Bornstein L., et al. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. Int J Radiat Oncol Biol Phys 32 (1995) 1309-1317
8. Lai C.-H., Hong J.-H., Hsuech S., et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases. An analysis of 891 cases. Cancer 85 (1999) 1537-1546
9. Morice P., Haie-Meder C., Rey A., et al. Radiotherapy and radical surgery for treatment of patients with bulky stage IB and II cervical carcinoma. Int J Gynecol Cancer 10 (2000) 239-246
10. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systemic review and meta-analysis. Lancet 358 (2001) 781-786
11. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
12. Rose P.G., Ali S., Watkins E., et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A Gynecologic Oncology Group study. J Clin Oncol 25 (2007) 2804-2810
13. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
14. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
15. Roberts K.B., Urdaneta N., Vera R., et al. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix. Radiat Oncol Invest 90 (2000) 206-223
16. Lorvidhaya V., Chitapanarux I., Sangruchi S., et al. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 1226-1232
17. Piver M.S., Rutledge F., and Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 49 (1974) 265-272
18. Nguyen D., de la Rochefordière A., Chauveinc L., et al. Concomitant pelvic irradiation and chemotherapy in locally advanced cervical carcinoma. A retrospective study of 92 patients treated at the Curie institute. Cancer/Radiother 6 (2002) 201-208
19. Houvenaeghel G., Lelièvre L., Gonzague-Casabianca L., et al. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol Oncol 100 (2006) 338-343
20. Touboul E., Lefranc J.P., Blondon J., et al. Preoperative radiation therapy and surgery in the treatment of "bulky" squamous cell carcinoma of the uterine cervix (stage Ib, IIa, and IIb operable tumors). Radiother Oncol 24 (1992) 32-40
21. Chassagne D., and Pierquin B. La plésiocuriethérapie des cancers du vagin par moulage plastique avec l'iridium 192 (préparation non radioactive). J Radiol Electrol Med Nucl 47 (1966) 82-93
22. International Committee on radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynecology. ICRU report 38. Bethesda, MD, 1985.
23. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1985) 457-481
24. LENT-SOMA Scales for all anatomic sites. Int J Radiat Oncol Biol Phys 31 (1995) 1049-1091
25. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 13-47
26. Mantel N., and Haenszel W. Chi-square with one degree of freedom: Extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58 (1963) 690-700
27. Cox D.R. Regression models and life table. J R Stat Soc 34 (1972) 187-220
28. Resbeut M., Cowen D., Viens P., et al. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol Oncol 54 (1994) 68-75
29. Houvenaeghel G., Buttarelli M., de Troyer J., et al. Surgical resection after chemo-radiotherapy for advanced cervical carcinoma. Cancer/Radiother 10 (2006) 471-476
30. Arai T., Nakano T., and Oka K. Local control prediction by histologic grading or radiation effects with drill biopsy specimens for uterine cervical cancer. Int J Radiat Oncol Biol Phys 27 (1993) 811-816
31. Hong J.H., Tsai C.S., Lai C.H., et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 249-257
32. Nijhuis E.R., Van der Zee A.G.J., in 't Hout B.A., et al. Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery. Int J Radiat Oncol Biol Phys 66 (2006) 699-705
33. 18F] fluoro-2-deoxy-D-glucose positron emission tomography. Cancer 100 (2004) 544-552
34. 18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: Response and outcome. J Clin Oncol 22 (2004) 2167-2171
35. Keys H.M., Bundy B.N., Stehman F.P., et al. Radiation therapy with or without extra facial hysterectomy for bulky stage IB cervical carcinoma: A randomized trial of the Gynecologic Oncology Group. Gynecol Oncol 89 (2003) 343-353
36. Grigsby P.W., Perez C.A., Chao K.S.C., et al. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix stage IB and IIA treated with preoperative irradiation and surgery. Int J Radiat Oncol Biol Phys 45 (1999) 645-651
37. Weiser E.B., Bundy B.N., Hoskins M.J., et al. Extraperitoneal versus transperitoneal selective para-aortic lymphadenectomy and radiation therapy in pretreatment surgical staging of advanced cervical carcinoma (a Gynecologic Oncology Group study). Gynecol Oncol 33 (1989) 283-289
38. Querleu D., Dargent D., Ansquer Y., et al. Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinoma. Cancer 88 (2000) 1883-1891
39. Barranger E., Grahek D., Cortez A., et al. Laparoscopic sentinel node procedure using a combination of patent blue and radio-isotope in women with cervical carcinoma. Cancer 97 (2003) 3003-3009
40. Haie C., Pejovic M.H., Gerbaulet A., et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol 11 (1988) 101-112
41. Rotman M., Pajak T.F., Choi K., et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stage IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 274 (1995) 387-393
42. Varia M.A., Bundy B.N., Deppe G., et al. Cervical carcinoma metastatic to para-aortic nodes: Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 42 (1998) 1015-1023
43. Grigsby P.W., Mutch D.G., Rader J., et al. Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. Int J Radiat Oncol Biol Phys 61 (2005) 444-449
44. Small Jr. W., Winter K., Levenback C., et al. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm 1 of RTOG 0116. Int J Radiat Oncol Biol Phys 68 (2007) 1081-1087
45. Beriwal S., Gan G.N., Heron D.E., et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 68 (2007) 166-171
46. Esthappan J., Mutic S., Malyapa R.S., et al. Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 58 (2004) 1289-1297
47. Van de Bunt L., Van der Heide U.A., Ketelaars M., et al. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: the impact of tumor regression. Int J Radiat Oncol Biol Phys 64 (2006) 189-196
48. Nag S., Cardenes H., Chang S., et al. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: Report from image-guided brachytherapy working group. Int J Radiat Oncol Biol Phys 60 (2004) 1160-1172
49. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from (GYN) GEC-ESTRO Working group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
50. Pötter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from (GYN) GEC-ESTRO Working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77